Similar Articles

Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study

Nuri Bayram, Özge Altuğ Gücenmez, Balahan Makay, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Yelda Sorguç, Aybüke Akaslan Kara, Kamile Ötiken Arıkan, İlker Devrim

DOI: 10.46497/ArchRheumatol.2023.9900

Issue: Volume 38 - Issue 4 - December 2023
1007 791

Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?

Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal

DOI: 10.46497/ArchRheumatol.2023.10035

Issue: Volume 38 - Issue 4 - December 2023
1076 842

New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases

Veysel Çam, Hülya Ercan Emreol, Seza Ozen

DOI: 10.46497/ArchRheumatol.2024.10911

Issue: Volume 39 - Issue 3 - September 2024
827 738

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10562

Issue: Volume 39 - Issue 3 - September 2024
574 417